# Mirvie

> Mirvie is a South San Francisco biotech using cell-free RNA signatures and machine learning to predict pregnancy complications - preeclampsia, preterm birth, fetal growth restriction - months before symptoms appear. Its flagship product Encompass is a blood test built on a foundational study of nearly 11,000 pregnancies.

- **Founded:** 2018
- **Headquarters:** South San Francisco, California, United States
- **Founders:** Maneesh Jain (Co-Founder & CEO), Stephen Quake (Co-Founder & Chair, Scientific Advisory Board)
- **Team size:** ~42 employees
- **Products:** Encompass, Mirvie RNA Platform
- **Notable:** FDA Breakthrough Device Designation for Encompass preeclampsia test, TIME Best Inventions of 2025 (Encompass), First RNA-based pregnancy-health company to receive CLIA certification

## Products & services

- **Encompass** — Blood test that uses cell-free RNA to predict a patient's personal risk of preeclampsia, paired with a preventive action plan and virtual support.
- **Mirvie RNA Platform** — Analyzes ~22,000 cell-free RNA transcripts per pregnancy from mother, placenta and baby, combined with machine learning, to surface molecular signatures of preterm birth, preeclampsia and fetal growth restriction.

## Achievements

- FDA Breakthrough Device Designation for Encompass preeclampsia test
- TIME Best Inventions of 2025 (Encompass)
- First RNA-based pregnancy-health company to receive CLIA certification
- Foundational research published in Nature
- $90M+ raised across rounds

## Latest updates

- **2025-10** — Encompass named to TIME's Best Inventions of 2025.
- **2025-09** — Additional venture funding closed.
- **2025-05** — Mirvie launches Encompass commercially in the US.
- **2024** — FDA Breakthrough Device designation granted; CLIA certification achieved.
- **2022-09** — Mirvie raises $60M to scale RNA platform.

## Links

- Website: https://mirvie.com
- LinkedIn: https://www.linkedin.com/company/mirvie
- Twitter/X: https://twitter.com/mirviedx
- Facebook: https://www.facebook.com/MirvieDx/

---

Profile page: https://yespress.io/mirvie
Published by YesPress — https://yespress.io
Last updated: 2026-06-28